Hospitalisation for monkeypox in Milan, Italy
- PMID: 35934310
- PMCID: PMC9760088
- DOI: 10.1016/j.tmaid.2022.102417
Hospitalisation for monkeypox in Milan, Italy
Abstract
During the current multi-country outbreak of human monkeypox the hospitalisation rate observed in Milan, Italy was 8.8%. Bacterial superinfection and severe perianal pain were the main cause of hospitalisation requiring antibiotic treatment and analgesic therapy. One patient was treated with Cidofovir. All hospitalised patients were discharged and the outcome was favourable with full recovery.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Figures
Similar articles
-
Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome.Infection. 2023 Apr;51(2):519-522. doi: 10.1007/s15010-022-01949-x. Epub 2022 Nov 10. Infection. 2023. PMID: 36355271
-
Human monkeypox outbreak: Epidemiological data and therapeutic potential of topical cidofovir in a prospective cohort study.J Am Acad Dermatol. 2023 May;88(5):1074-1082. doi: 10.1016/j.jaad.2022.10.043. Epub 2022 Nov 29. J Am Acad Dermatol. 2023. PMID: 36455826 Free PMC article.
-
A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox.J Microbiol Immunol Infect. 2022 Oct;55(5):795-802. doi: 10.1016/j.jmii.2022.08.016. Epub 2022 Sep 6. J Microbiol Immunol Infect. 2022. PMID: 36115792 Free PMC article.
-
Monkeypox: What do we know so far? A short narrative review of literature.J Assoc Physicians India. 2022 Jul;70(7):11-12. doi: 10.5005/japi-11001-0071. J Assoc Physicians India. 2022. PMID: 35833402 Review.
-
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments.J Pharm Pharm Sci. 2022;25:297-322. doi: 10.18433/jpps33138. J Pharm Pharm Sci. 2022. PMID: 36130588 Review.
Cited by
-
Whole-genome sequencing of hMPXV1 in five Italian cases confirms the occurrence of the predominant epidemic lineage.J Med Virol. 2023 Feb;95(2):e28493. doi: 10.1002/jmv.28493. J Med Virol. 2023. PMID: 36633196 Free PMC article.
-
Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine.Front Microbiol. 2023 Jul 21;14:1203355. doi: 10.3389/fmicb.2023.1203355. eCollection 2023. Front Microbiol. 2023. PMID: 37547674 Free PMC article.
-
Emerging evidence on Monkeypox: resurgence, global burden, molecular insights, genomics and possible management.Front Cell Infect Microbiol. 2023 Apr 19;13:1134712. doi: 10.3389/fcimb.2023.1134712. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37153147 Free PMC article. Review.
-
Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review.Life (Basel). 2023 Sep 26;13(10):1969. doi: 10.3390/life13101969. Life (Basel). 2023. PMID: 37895350 Free PMC article. Review.
-
Assessment and management of secondary bacterial infections complicating Mpox (Monkeypox) using a telemedicine service. A prospective cohort study.Int J STD AIDS. 2023 Jun;34(7):434-438. doi: 10.1177/09564624231162760. Epub 2023 Mar 15. Int J STD AIDS. 2023. PMID: 36920941 Free PMC article.
References
-
- Girometti N., Byrne R., Bracchi M., Heskin J., McOwan A., Tittle V., et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00411-X. - DOI - PMC - PubMed
-
- Jezek Z., Szczeniowski M., Paluku K.M., Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis. 1987;156:293–298. - PubMed
-
- Ogoina D., Iroezindu M., James H.I., Oladokun R., Yinka-Ogunleye A., Wakama P., et al. Clinical course and outcome of human monkeypox in Nigeria. Clin Infect Dis. 2020;71(8):e210–e214. - PubMed